Isabella Presch, MD, MBA

Isabella Presch, MD, MBA, is a Senior Medical Director.

Ines Pagel-Langenickel, MD

Ines Pagel-Langenickel, MD, is an Executive Medical Director of CVMER (cardiovascular, metabolic, endocrine and renal) at Fortrea.

Hannah Simonds

Hannah Simonds is Director of Patient Recruitment and Engagement at Fortrea, having joined the organization in June 2020.

George Vamvakias

• 33 years in industry with experience in pharmaceutical and medical device product development 

Friedrich Wieser, MD

Friedrich (Fritz) Wieser, MD, is an OB/GYN who received his MD from the Vienna Medical University (Vienna, Austria). After completing his gynecology residency at the Dept.

Frederick Derosier, DO

Frederick Derosier, DO, is Fortrea’s Vice President for Rare Diseases, Advanced Therapies, and Pediatrics and additionally serves as Therapeutic Strategy Lead for

Diana Aguirre, MD

Diana Aguirre, MD, is Senior Medical Director in oncology for Fortrea Clinical Development Services, based in France. Dr.

David Hoelscher, MD

Dr.

Darby Thomas, PhD

Darby Thomas, PhD, is the Scientific Director of Cell & Gene Therapies.

Daniel Gandia, MD

Dr. Gandia is a physician with more than 30 years of experience in clinical oncology and the pharmaceutical industry.